Cell Biotech Co (049960.KQ) Stock Price

Cell Biotech Co Price

CLOSED
15,100.00KRW+250.00 (+1.67 %)
Market closed

Revenue has compounded at 9.9% per year over the past 19 years to 53.13 B KRW. Earnings per share have grown at 45.2% per year over the last 12 years. Cell Biotech Co's net margin stands at 19.1%, down from 22.2% several years earlier. Cell Biotech Co currently offers a dividend yield of about 2.98%. The payout ratio is around 22% of earnings. The dividend has grown at 8.7% per year over the past 18 years. The stock trades about 31% above its 52-week low.

Cell Biotech Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cell Biotech Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cell Biotech Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cell Biotech Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cell Biotech Co Stock Price History
DateCell Biotech Co Price
7/31/202615,100.00 KRW
7/30/202614,850.00 KRW
7/29/202615,010.00 KRW
7/28/202614,960.00 KRW
7/27/202615,200.00 KRW
7/24/202615,250.00 KRW
7/23/202615,220.00 KRW
7/22/202615,250.00 KRW
7/21/202615,040.00 KRW
7/20/202615,200.00 KRW
7/16/202615,400.00 KRW
7/15/202615,420.00 KRW
7/14/202615,420.00 KRW
7/13/202615,180.00 KRW
7/10/202615,350.00 KRW
7/9/202614,850.00 KRW
7/8/202615,060.00 KRW
7/7/202615,320.00 KRW
7/6/202615,280.00 KRW
7/3/202615,550.00 KRW
7/2/202615,300.00 KRW
7/1/202615,700.00 KRW
6/30/202615,090.00 KRW
6/29/202615,120.00 KRW
6/26/202615,000.00 KRW
6/25/202615,180.00 KRW
6/24/202615,170.00 KRW
6/23/202615,200.00 KRW
6/22/202615,130.00 KRW
6/19/202615,470.00 KRW
6/18/202615,930.00 KRW
6/17/202616,250.00 KRW
6/16/202616,200.00 KRW
6/15/202616,340.00 KRW
6/12/202616,570.00 KRW
6/11/202616,150.00 KRW
6/10/202616,140.00 KRW
6/9/202616,460.00 KRW
6/8/202615,310.00 KRW
6/5/202616,330.00 KRW
6/4/202616,900.00 KRW
6/2/202616,600.00 KRW
6/1/202617,360.00 KRW
5/29/202617,500.00 KRW
5/28/202618,110.00 KRW
5/27/202618,060.00 KRW
5/26/202618,110.00 KRW
5/22/202618,080.00 KRW
5/21/202617,580.00 KRW
5/20/202617,650.00 KRW
5/19/202617,000.00 KRW
5/18/202617,380.00 KRW
5/15/202617,000.00 KRW
5/14/202617,210.00 KRW
5/13/202617,190.00 KRW
5/12/202616,890.00 KRW
5/11/202617,090.00 KRW
5/8/202616,450.00 KRW
5/7/202615,860.00 KRW
5/6/202615,700.00 KRW
5/4/202615,840.00 KRW
4/30/202616,000.00 KRW
4/29/202616,230.00 KRW
4/28/202616,200.00 KRW
4/27/202616,220.00 KRW
4/24/202616,160.00 KRW
4/23/202616,090.00 KRW
4/22/202615,970.00 KRW
4/21/202615,970.00 KRW
4/20/202615,990.00 KRW
4/17/202616,380.00 KRW
4/16/202616,550.00 KRW
4/15/202615,200.00 KRW
4/14/202615,100.00 KRW
4/13/202614,880.00 KRW
4/10/202615,120.00 KRW
4/9/202614,930.00 KRW
4/8/202614,640.00 KRW
4/7/202614,450.00 KRW
4/6/202614,140.00 KRW
4/3/202614,230.00 KRW
4/2/202614,160.00 KRW
4/1/202614,400.00 KRW
3/31/202614,000.00 KRW
3/30/202614,340.00 KRW
3/27/202614,690.00 KRW
3/26/202614,380.00 KRW
3/25/202614,450.00 KRW
3/24/202614,000.00 KRW
3/23/202613,950.00 KRW
3/20/202614,360.00 KRW
3/19/202613,930.00 KRW
3/18/202614,110.00 KRW
3/17/202614,070.00 KRW
3/16/202614,000.00 KRW
3/13/202614,400.00 KRW
3/12/202614,610.00 KRW
3/11/202614,390.00 KRW
3/10/202613,880.00 KRW
3/9/202613,600.00 KRW
3/6/202614,070.00 KRW
3/5/202613,960.00 KRW
2/26/202614,420.00 KRW
2/25/202615,090.00 KRW
2/24/202614,780.00 KRW
2/23/202615,420.00 KRW
2/20/202613,930.00 KRW
2/19/202613,970.00 KRW
2/13/202613,750.00 KRW
2/12/202613,700.00 KRW
2/11/202613,580.00 KRW
2/10/202613,470.00 KRW
2/9/202613,440.00 KRW
2/6/202613,330.00 KRW
2/5/202613,750.00 KRW
2/4/202613,780.00 KRW
2/3/202613,620.00 KRW
2/2/202613,690.00 KRW
1/30/202613,800.00 KRW
1/29/202613,200.00 KRW
1/28/202613,250.00 KRW
1/27/202613,430.00 KRW
1/26/202613,220.00 KRW
1/23/202613,090.00 KRW
1/22/202612,980.00 KRW
1/21/202612,790.00 KRW
1/20/202613,020.00 KRW
1/19/202612,820.00 KRW
1/16/202613,100.00 KRW
1/15/202613,140.00 KRW
1/14/202613,000.00 KRW
1/13/202612,900.00 KRW
1/12/202613,020.00 KRW
1/9/202612,950.00 KRW
1/8/202612,670.00 KRW
1/7/202612,890.00 KRW
1/6/202612,760.00 KRW
1/5/202613,130.00 KRW
1/2/202613,030.00 KRW
12/30/202513,110.00 KRW
12/29/202513,190.00 KRW
12/26/202513,670.00 KRW
12/24/202513,700.00 KRW
12/23/202513,760.00 KRW
12/22/202513,760.00 KRW
12/19/202513,730.00 KRW
12/18/202513,640.00 KRW
12/17/202513,780.00 KRW
12/16/202513,780.00 KRW
12/15/202513,840.00 KRW
12/12/202513,840.00 KRW
12/11/202513,940.00 KRW
12/10/202513,550.00 KRW
12/9/202513,320.00 KRW
12/8/202513,530.00 KRW
12/5/202514,020.00 KRW
12/4/202514,020.00 KRW
12/3/202514,160.00 KRW
12/2/202514,330.00 KRW
12/1/202514,320.00 KRW
11/28/202513,310.00 KRW
11/27/202513,100.00 KRW
11/26/202513,080.00 KRW
11/25/202512,850.00 KRW
11/24/202512,790.00 KRW
11/21/202512,810.00 KRW
11/20/202512,350.00 KRW
11/19/202511,990.00 KRW
11/18/202512,030.00 KRW
11/17/202512,170.00 KRW
11/14/202512,300.00 KRW
11/13/202512,500.00 KRW
11/12/202512,500.00 KRW
11/11/202511,810.00 KRW
11/10/202511,850.00 KRW
11/7/202511,740.00 KRW
11/6/202511,900.00 KRW
11/5/202511,500.00 KRW
11/4/202511,700.00 KRW
11/3/202511,660.00 KRW
10/31/202511,750.00 KRW
10/30/202511,800.00 KRW
10/29/202511,750.00 KRW
10/28/202511,790.00 KRW
10/27/202511,720.00 KRW
10/24/202511,740.00 KRW
10/23/202511,950.00 KRW
10/22/202512,050.00 KRW
10/21/202512,060.00 KRW
10/20/202512,070.00 KRW
10/17/202512,040.00 KRW
10/16/202512,210.00 KRW
10/15/202512,350.00 KRW
10/14/202512,300.00 KRW
10/13/202512,220.00 KRW
10/10/202512,270.00 KRW
10/2/202512,440.00 KRW
10/1/202512,520.00 KRW
9/30/202512,350.00 KRW
9/29/202512,400.00 KRW
9/26/202512,400.00 KRW
9/25/202512,420.00 KRW
9/24/202512,470.00 KRW
9/23/202512,670.00 KRW
9/22/202512,880.00 KRW
9/19/202512,630.00 KRW
9/18/202512,620.00 KRW
9/17/202512,690.00 KRW
9/16/202512,810.00 KRW
9/15/202512,820.00 KRW
9/12/202512,890.00 KRW
9/11/202512,960.00 KRW
9/10/202513,030.00 KRW
9/9/202512,920.00 KRW
9/8/202512,890.00 KRW
9/5/202512,880.00 KRW
9/4/202512,660.00 KRW
9/3/202512,580.00 KRW
9/2/202512,560.00 KRW
9/1/202512,680.00 KRW
8/29/202512,870.00 KRW
8/28/202512,950.00 KRW
8/27/202512,840.00 KRW
8/26/202512,760.00 KRW
8/25/202512,790.00 KRW
8/22/202512,710.00 KRW
8/21/202512,700.00 KRW
8/20/202512,550.00 KRW
8/19/202512,690.00 KRW
8/18/202512,890.00 KRW
8/14/202512,840.00 KRW
8/13/202512,860.00 KRW
8/12/202512,750.00 KRW
8/11/202512,860.00 KRW
8/8/202513,140.00 KRW
8/7/202513,150.00 KRW
8/6/202513,220.00 KRW
8/5/202513,320.00 KRW
8/4/202513,150.00 KRW
Access this data via the Eulerpool API
Get Free API Key

Cell Biotech Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
62.54 B KRW
21.67 B KRW
19.38 B KRW
Jan 1, 2019
45.96 B KRW
5.79 B KRW
7.23 B KRW
Jan 1, 2020
45.58 B KRW
3.67 B KRW
3.19 B KRW
Jan 1, 2021
46.87 B KRW
7.26 B KRW
10.38 B KRW
Jan 1, 2022
50.53 B KRW
6.07 B KRW
8.28 B KRW
Jan 1, 2023
53.79 B KRW
2.11 B KRW
6.30 B KRW
Jan 1, 2024
49.91 B KRW
6.80 B KRW
15.13 B KRW
Jan 1, 2025
53.13 B KRW
7.91 B KRW
10.13 B KRW

Cell Biotech Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 3, 2026, 12:10 PM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
19.5923.3225.8931.6040.7749.5058.2861.0662.5445.9645.5846.8750.5353.7949.9153.13
23.9019.0111.0322.0529.0221.4317.724.772.44-26.52-0.822.837.796.46-7.206.44
64.32165.6466.1369.0472.3776.9278.0679.3278.1076.6176.1876.1375.1172.4672.2572.70
12.6038.6217.1221.8129.5038.0845.4948.4348.8435.2134.7335.6837.9538.9736.0638.62
6.195.746.539.3912.9118.7621.5622.6321.675.793.677.266.072.116.807.91
31.5824.6225.2429.7231.6637.8937.0037.0734.6512.618.0415.4812.013.9313.6114.90
4.895.206.147.8010.4017.5118.5018.2019.387.233.1910.388.286.3015.1310.13
14.506.4018.0327.0233.3868.285.67-1.636.52-62.70-55.90225.59-20.25-23.88139.98-33.06
150.00150.00150.00150.00150.00400.00550.00550.00600.00600.00450.00450.00450.00450.00450.00450.00
50.00––––166.6737.50–9.09–-25.00–––––
8.007.507.507.507.507.727.506.637.507.507.507.507.507.507.507.50
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cell Biotech Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cell Biotech Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cell Biotech Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cell Biotech Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cell Biotech Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cell Biotech Co stock margins

The Cell Biotech Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cell Biotech Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cell Biotech Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
78.10 %
34.66 %
30.99 %
Jan 1, 2019
76.61 %
12.61 %
15.73 %
Jan 1, 2020
76.18 %
8.05 %
7.00 %
Jan 1, 2021
76.13 %
15.48 %
22.15 %
Jan 1, 2022
75.11 %
12.01 %
16.39 %
Jan 1, 2023
72.46 %
3.93 %
11.72 %
Jan 1, 2024
72.25 %
13.62 %
30.31 %
Jan 1, 2025
72.70 %
14.90 %
19.06 %

Cell Biotech Co Stock Revenue, EBIT, Earnings per Share

The Cell Biotech Co earnings per share therefore indicates how much revenue Cell Biotech Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
8,334.71 KRW
2,888.44 KRW
2,583.19 KRW
Jan 1, 2019
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2020
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2021
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2022
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2023
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2024
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2025
0.00 KRW
0.00 KRW
0.00 KRW

Cell Biotech Co business model & stock analysis

Cell Biotech Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cell Biotech Co historical P/E ratio, EBIT multiple, and P/S ratio

Cell Biotech Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cell Biotech Co shares outstanding

The number of shares of Cell Biotech Co was 7.5 M in 2025. This indicates how many shares Cell Biotech Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
7.50 M Stocks
Jan 1, 2019
7.50 M Stocks
Jan 1, 2020
7.50 M Stocks
Jan 1, 2021
7.50 M Stocks
Jan 1, 2022
7.50 M Stocks
Jan 1, 2023
7.50 M Stocks
Jan 1, 2024
7.50 M Stocks
Jan 1, 2025
7.50 M Stocks

Cell Biotech Co Dividend History

19 years of dividend payments

YearAnnual DividendYoY ChangePayments
2025450.00KRW 0.0%—
2024450.00KRW 0.0%1×
2023450.00KRW 0.0%1×
2022450.00KRW 0.0%1×
2021450.00KRW 0.0%1×
2020450.00KRW↓ 25.0%1×
2019600.00KRW 0.0%1×
2018600.00KRW↑ 9.1%1×
2017550.00KRW 0.0%1×
2016550.00KRW↑ 37.5%1×

Cell Biotech Co dividend history and estimates

In 2025, Cell Biotech Co paid a dividend amounting to 450.00 KRW. Dividend means that Cell Biotech Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
600.00 KRW
0.00 KRW
Jan 1, 2019
600.00 KRW
0.00 KRW
Jan 1, 2020
450.00 KRW
0.00 KRW
Jan 1, 2021 (e)
0.00 KRW
450.00 KRW
Jan 1, 2022
450.00 KRW
0.00 KRW
Jan 1, 2023
450.00 KRW
0.00 KRW
Jan 1, 2024
450.00 KRW
0.00 KRW
Jan 1, 2025
450.00 KRW
0.00 KRW

Cell Biotech Co dividend payout ratio

In 2025, Cell Biotech Co had a payout ratio of 21.64%. The payout ratio indicates the percentage of the company's profits that Cell Biotech Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
23.23 %
Jan 1, 2019
21.18 %
Jan 1, 2020
21.48 %
Jan 1, 2021
21.96 %
Jan 1, 2022
21.54 %
Jan 1, 2023
21.66 %
Jan 1, 2024
21.72 %
Jan 1, 2025
21.64 %
Price targets and forecasts for Cell Biotech Co are not yet available.

Cell Biotech Co shareholder structure

% Name
25.40033%
Jeong (Myeong Jun)
Jeong (Myeong Jun)
4.38347%
Yun (Yeong Ok)
Yun (Yeong Ok)
3.36305%
Yun (Seong Bae)
Yun (Seong Bae)
0.62245%
Jeong (Hye Ji)
Jeong (Hye Ji)
0.62245%
Jeong (Yu Suk)
Jeong (Yu Suk)
0.31526%
Niche Asset Management Limited
Niche Asset Management Limited

Cell Biotech Co Executives and Management Board

4 members · avg. age 51 · 0 % women

Management

MJ

Myeong Jun Jung (55)

Chief Executive Officer, Director

–
SY

Seong Bae Yoon (48)

Assistant Managing Director

–
YS

Yeong Suk Song (50)

Internal Auditor

–

Board of Directors

YY

Yeong Ok Yoon (50)

Director

–

Cell Biotech Co Supply Chain

Frequently asked questions about Cell Biotech Co

6 analysts currently rate the Cell Biotech Co stock: 0 recommend buying, 3 holding and 3 selling.

Cell Biotech Co Analyst Price Targets 2026

Converted at the current exchange rate, the Cell Biotech Co share trades at 9.11 EUR (15,100.00 KRW).

No history available for Cell Biotech Co.

The revenue cannot currently be calculated for Cell Biotech Co.

The profit cannot currently be calculated for Cell Biotech Co.

The P/E ratio cannot be calculated for Cell Biotech Co at the moment.

The P/S cannot be calculated for Cell Biotech Co currently.

The Eulerpool Quality Score for Cell Biotech Co is 3/10.

The ISIN of Cell Biotech Co is KR7049960008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cell Biotech Co is 049960.KQ. The ticker symbol is used to trade Cell Biotech Co shares on the stock exchange.

Over the past 12 months, Cell Biotech Co paid a dividend of 450.00 KRW . This corresponds to a dividend yield of about 2.98 %. For the coming 12 months, Cell Biotech Co is expected to pay a dividend of 450.00 KRW.

The current dividend yield of Cell Biotech Co is 2.98 %.

Cell Biotech Co pays a dividend, distributed in the months of , , , .

Cell Biotech Co paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 450.00 KRW are expected. This corresponds to a dividend yield of 2.98 %.

Cell Biotech Co is assigned to the 'Health' sector.

To receive the latest dividend of Cell Biotech Co from amounting to 450 KRW, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Cell Biotech Co distributed 450 KRW as dividends.

The dividends of Cell Biotech Co are distributed in KRW.

All fundamentals and in-depth analysis of Cell Biotech Co

Our stock analysis for Cell Biotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cell Biotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cell Biotech Co Stock
Cell Biotech Co Revenue→
Cell Biotech Co Stock
Cell Biotech Co Net Income→
Cell Biotech Co Stock
Cell Biotech Co P/E→
Cell Biotech Co Stock
Cell Biotech Co P/S→
Cell Biotech Co Stock
Cell Biotech Co EBIT→
Cell Biotech Co Stock
Cell Biotech Co Dividend→
Cell Biotech Co Stock
Cell Biotech Co Directors Dealings→
Cell Biotech Co Stock
Cell Biotech Co Stocks→
Cell Biotech Co Stock
Cell Biotech Co Market capitalization→
Cell Biotech Co Stock
Cell Biotech Co Debt→
Cell Biotech Co Stock
Cell Biotech Co Liabilities→
Cell Biotech Co Stock
Cell Biotech Co Equity→
Cell Biotech Co Stock
Cell Biotech Co AAQS→
Cell Biotech Co Stock
Cell Biotech Co Employees→
Cell Biotech Co Stock
Cell Biotech Co ROE→
Cell Biotech Co Stock
Cell Biotech Co ROA→
Cell Biotech Co Stock
Cell Biotech Co ROCE→
Cell Biotech Co Stock
Cell Biotech Co News→
Cell Biotech Co Stock
Cell Biotech Co Analyst Price Targets→

Health Stocks

Cell SourceCelestraCellaVisionCelemicsCelldex TherapeuticsCelcuityCellectar BiosciencesCEL-SCICellectisCegedimCellid CoCedar CoAll Stocks A–Z →